Gingival oergrowth in dgs asociated with cinically rlevant cclosporine bood lvels: Observations in a canine renal transplantation model

Veterinary Surgery

Volumn 37, Issue 3, 2008, Pages 247-253

  Nam, Hyun Sook ^b   McAnulty, Jonathon F ^b   Kwak, Ho Hyun ^b   Yoon, Byung Il ^b   Hyun, Changbaig ^b   Kim, Wan Hee ^b   Woo, Heung Myong ^a  

^a Kangwon National University   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DOG; DOG DISEASE; GINGIVA HYPERPLASIA; GRAFT REJECTION; KIDNEY TRANSPLANTATION; PATHOLOGY;

ANIMALS; AZATHIOPRINE; CYCLOSPORINE; DOG DISEASES; DOGS; GINGIVAL HYPERPLASIA; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PREDNISOLONE;

EID: 41749084383     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/j.1532-950X.2008.00373.x     Document Type: Article

References (43)

1. Robson DC, Burton GG: Cyclosporin: applications in small animal dermatology. Vet Dermatol 14: 1 9, 2003
2. House AK, Guitian J, Gregory SP, et al: Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs. Vet Surg 35: 543 549, 2006
3. Kaufmann Y, Chang AE, Robb RJ, et al: Mechanism of action of cyclosporine A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas. J Immunol 133: 3107 3111, 1984
4. Gelfand EW, Cheung RK, Mills GB: The cyclosporine inhibits lymphocyte activation at more than one site. J Immunol 138: 1115 1120, 1987
5. Ptachcinski RJ, Burckart GJ, Venkataramanan R: Cyclosporine. Drug Intell Clin Pharm 19: 90 100, 1985
6. Guaguere E, Steffan J, Olivry T: Cyclosporin A; a new drug in the field of canine dermatology. Vet Dermatol 15: 61 74, 2004
7. Kyriakides G, Miller J: Use of cyclosporine in renal transplantation. Trans Proc 36: 167 172, 2004
8. Morisaki I, Akiyama YM, Miyawaki YN, et al: Positive correlation between blood cyclosporin A level and severity of gingival overgrowth in rats. J Periodontol 68: 7 11, 1997
9. Vescovi P, Meleti M, Manfredi M, et al: Cyclosporin-induced gingival overgrowth: a clinical-epidemiological evaluation of 121 Italian renal transplant recipients. J Periodontol 76: 1259 1264, 2005
10. Gregory CR, Kyles AE, Bernsteen L, et al: Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy. Vet Surg 35: 105 112, 2006
11. McKaig SJ, Kelly D, Shaw L: Investigation of the effect of FK506 (tacrolimus) and cyclosporin on gingival overgrowth following paediatric liver transplantation. Int J Paediatr Dent 12: 398 403, 2002
12. Hernandez G, Arriba L, Frias MC, et al: Conversion from cyclosporin A to tacrolimus as a non-surgical alternative to reduce gingival enlargement: a preliminary case series. J Periodontol 74: 1816 1823, 2003
13. Prabhu A, Mehta DS: A morphologic comparison of gingival changes influenced by cyclosporin and tacrolimus in rats: an experimental study. J Periodontol 77: 265 270, 2006
14. Fukuse T, Hasegawa S, Hirai T, et al: Optimal dose of FK 506 in canine lung allotransplantation. Trans Proc 24: 1399 1400, 1992
15. Griffin AD, Hawthorne WJ, Inutsuka S, et al: FK 506 in canine renal transplantation. Trans Proc 24: 2305 2306, 1992
16. Fujisawa T, Saitoh Y, Urabe N, et al: Dose study of the immunosuppresion of FK 506 in canine lung allo-transplantation. Jpn J Surg 23: 338 343, 1993
17. Vaden SL: Cyclosporine and Tacrolimus. Semin Vet Med Surg (Small Anim) 12: 161 166, 1997
18. Birraux J, Kirby JA, Thomason JM, et al: The effect of cyclosporin on cell division and apoptosis in human oral keratinocytes. J Periodontal Res 41: 297 302, 2006
19. Martin S, Dyer PA: The definition of HLA specificities by cytotoxicity. Transpl Immunol 2: 108 111, 1994
20. Bernsteen L, Gregory CR, Kyles AE, et al: Microemulsified cyclosporine-based immunosuppression for the prevention of acute renal allograft rejection in unrelated dogs: preliminary experimental study. Vet Surg 32: 213 219, 2003
21. Pernu HE, Pernu LM, Huttunen KR, et al: Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 63: 548 553, 1992
22. Wilson RF, Morel A, Smith D, et al: Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapies. J Clin Periodontol 25: 457 464, 1998
23. Friskopp J, Klintmalm G: Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 10: 85 92, 1986
24. Bokenkamp A, Bohnhorst B, Beier C, et al: Nifiedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatriatric Nephrology 8: 181 185, 1994
25. Radowicz SN, Power HT: Long-term use of cyclosporine in the treatment of canine atopic dermatitis. Vet Dermatol 16: 81 86, 2005
26. Mathews KA, Sukhiani HR: Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs. J Am Vet Med Assoc 211: 1249 1253, 1997
27. Noli C, Toma S: Three cases of immune-mediated adnexal skin disease treated with cyclosporine. Vet Dermatol 17: 85 92, 2006
28. Wysocki GP, Gretzinger HA, Laupacis A, et al: Fiburous hyperplasia of the gingiva; a side effect of cyclosporin A therapy. Oral Surg 55: 274 278, 1983
29. Tyldesley WR, Rotter E: Gingival hyperplasia induced by cyclosporin-A. Br Dent J 157: 305 309, 1984
30. Doufexi A, Mina M, Ioannidou E: Gingival overgrowth in children: epidemiology, pathogenesis, and complications. A literature review. J Periodontol 76: 3 10, 2005
31. Mariani G, Calastrini C, Carinci F, et al: Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth. J Periodontol 67: 21 27, 1996
32. Gagliano N, Moscheni C, Dellavia C, et al: Effect of cyclosporin A on human gingival fibroblast collagen turnover in relation to the development of gingival overgrowth: an in vitro study. Biomed Pharmacother 58: 231 238, 2004
33. Bulut OE, Sokmensuer LK, Bulut S, et al: Immunohistochemical study of cyclosporin-induced gingival overgrowth in renal transplant recipients. J Periodontol 75: 1655 1662, 2004
34. Cetinkaya BO, Acikgoz G, Ayas B, et al: Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats. J Periodontol 77: 54 60, 2006
35. Chae HJ, Ha MS, Yun DH, et al: Mechanism of cyclosporine-induced overgrowth in gingiva. J Dent Res 85: 515 519, 2006
36. Dannewitz B, Edrich C, Tomakidi P, et al: Elevated levels of gene expression for collagen and decorin in human gingival overgrowth. J Clin Periodontol 33: 510 516, 2006
37. Radwan-Oczko M, Boratynska M, Zietek M, et al: The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. J Periodontol 77: 865 873, 2006
38. Seibel W, Yahia NA, McCleary LB, et al: Cyclosporine-induced gingival overgrowth in beagle dogs. J Oral Pathol Med 18: 240 245, 1989
39. Mathews KA, Holmberg DL, Miller CW: Kidney transplantation in dogs with naturally occurring end-stage renal disease. J Am Anim Hosp Assoc 36: 294 301, 2000
40. Gomez E, Sanchez-Nunez M, Sanchez JE, et al: Treatment of cyclosporin-induced gingival hyperplasia with azithromycin. Nephrol Dial Transplant 12: 2694 2697, 1997
41. Wirnsberger GH, Pfragner R, Mauric A, et al: Effect of antibiotic treatment with Azithromycin on Cyclosporine A induced gingival hyperplasia among renal transplant recipients. Transplant Proc 30: 2117 2119, 1998
42. Sanchez-Nunez ML, Gomez E, Sanchez JE, et al: Clarithromycin in the treatment of cyclosporine-associated gingival hyperplasia. Nephrol Dial Transplant 12: 2040 2041, 1997
43. Gladue RP, Snider ME: Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother 34: 1056 1060, 1990